ROBERT BLACK: Open Payments
NPI 1861985657 · MEADVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,561 in 72 payments from 10 companies in 2025. Trend: 2023 $380 · 2024 $756 · 2025 $1,561
Food & beverage: $1,348Education: $213
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 21 | $502 |
| Vanda Pharmaceuticals Inc. | 9 | $194 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $191 |
| Collegium Pharmaceutical, Inc. | 12 | $179 |
| Alkermes, Inc. | 8 | $137 |
| ABBVIE INC. | 6 | $125 |
| Neurocrine BioSciences, Inc. | 4 | $85 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Lundbeck LLC | 3 | $63 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
Products named: CAPLYTA, Jornay PM, FANAPT, AUSTEDO XR, UZEDY, VRAYLAR, REXULTI, INGREZZA.
Industry payments across PA — which companies pay providers there.
